Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Maryam Asgari to Humans

This is a "connection" page, showing publications Maryam Asgari has written about Humans.

 
Connection Strength
  
 
 
1.556
  
  1. Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 01 05; 7(1):33.
    View in: PubMed
    Score: 0.025
  2. Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 07 01; 159(7):788-790.
    View in: PubMed
    Score: 0.024
  3. Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 04 18; 329(15):1259-1260.
    View in: PubMed
    Score: 0.024
  4. Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 04; 143(4):664-667.
    View in: PubMed
    Score: 0.023
  5. Kim Y, Yin J, Huang H, Jorgenson E, Choquet H, Asgari MM. Genome-wide association study of actinic keratosis identifies new susceptibility loci implicated in pigmentation and immune regulation pathways. Commun Biol. 2022 04 21; 5(1):386.
    View in: PubMed
    Score: 0.022
  6. Ashrafzadeh S, Gupta S, Fiorino AM, Cafiero-Fonseca ET, Ferris TG, Asgari MM. The effectiveness of an electronic clinical-decision support tool embedded into the patient medical record at the point of care to guide Mohs surgery utilization: A cohort study. J Am Acad Dermatol. 2022 07; 87(1):166-167.
    View in: PubMed
    Score: 0.021
  7. Pan CX, Jee YH, Moore KJ, Kraft P, Asgari MM. Relationship between body mass index and atopic dermatitis: a Mendelian randomization approach in exploring causality: a critical appraisal. Br J Dermatol. 2021 06; 184(6):1045-1046.
    View in: PubMed
    Score: 0.021
  8. Jorgenson E, Choquet H, Yin J, Hoffmann TJ, Banda Y, Kvale MN, Risch N, Schaefer C, Asgari MM. Genetic ancestry, skin pigmentation, and the risk of cutaneous squamous cell carcinoma in Hispanic/Latino and non-Hispanic white populations. Commun Biol. 2020 12 14; 3(1):765.
    View in: PubMed
    Score: 0.020
  9. Yao Q, Epstein CB, Banskota S, Issner R, Kim Y, Bernstein BE, Pinello L, Asgari MM. Epigenetic Alterations in Keratinocyte Carcinoma. J Invest Dermatol. 2021 05; 141(5):1207-1218.
    View in: PubMed
    Score: 0.020
  10. Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis. JAMA Dermatol. 2020 10 01; 156(10):1066-1073.
    View in: PubMed
    Score: 0.020
  11. Ashrafzadeh S, Kim Y, Peters GA, Lee H, Asgari MM. Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa. Br J Dermatol. 2020 11; 183(5):962-964.
    View in: PubMed
    Score: 0.020
  12. Kim Y, Zhang F, Su K, LaRochelle M, Callahan M, Fisher D, Wharam JF, Asgari MM. Perioperative Serum 25-Hydroxyvitamin D Levels as a Predictor of Postoperative Opioid Use and Opioid Use Disorder: a Cohort Study. J Gen Intern Med. 2020 09; 35(9):2545-2552.
    View in: PubMed
    Score: 0.020
  13. Kim Y, Jorgenson E, Asgari MM. Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis. Br J Dermatol. 2020 09; 183(3):415-416.
    View in: PubMed
    Score: 0.019
  14. Chavez A, Quesenberry CP, Darbinian J, Asgari MM. Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk. J Invest Dermatol. 2020 12; 140(12):2353-2358.
    View in: PubMed
    Score: 0.019
  15. Weintraub GS, Su KA, Demehri S, Asgari MM. Enhancing the process for care delivery in a dermatology specialty clinic. J Am Acad Dermatol. 2020 Oct; 83(4):1181-1184.
    View in: PubMed
    Score: 0.019
  16. Ashrafzadeh S, Metlay JP, Choudhry NK, Emmons KM, Asgari MM. Using Implementation Science to Optimize the Uptake of Evidence-Based Medicine into Dermatology Practice. J Invest Dermatol. 2020 05; 140(5):952-958.
    View in: PubMed
    Score: 0.019
  17. Park AJ, Weintraub GS, Asgari MM. Leveraging the electronic health record to improve dermatologic care delivery: The importance of finding structure in data. J Am Acad Dermatol. 2020 03; 82(3):773-775.
    View in: PubMed
    Score: 0.019
  18. Roberts MR, Sordillo JE, Kraft P, Asgari MM. Sex-Stratified Polygenic Risk Score Identifies Individuals at Increased Risk of Basal Cell Carcinoma. J Invest Dermatol. 2020 05; 140(5):971-975.
    View in: PubMed
    Score: 0.019
  19. Kim Y, Wojciechowski D, Pattanayak V, Lee H, Asgari MM. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients. J Invest Dermatol. 2020 05; 140(5):995-1002.
    View in: PubMed
    Score: 0.019
  20. Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, Reuss D, Wu H, Robinson WA, Olshen A, von Deimling A, Kwok PY, Bastian BC, Asgari MM. Targeted Genomic Profiling of Acral Melanoma. J Natl Cancer Inst. 2019 10 01; 111(10):1068-1077.
    View in: PubMed
    Score: 0.019
  21. Kim Y, Su KA, Asgari MM. Correlates of multiple cutaneous squamous cell carcinoma: A retrospective cohort study. J Am Acad Dermatol. 2020 02; 82(2):497-499.
    View in: PubMed
    Score: 0.018
  22. Karas L, Lu CY, Agrawal PB, Asgari MM. The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers. J Am Acad Dermatol. 2019 09; 81(3):867-877.
    View in: PubMed
    Score: 0.018
  23. Asgari MM, Carr PL, Bates CK. Closing the Gender Wage Gap and Achieving Professional Equity in Medicine. JAMA. 2019 May 07; 321(17):1665-1666.
    View in: PubMed
    Score: 0.018
  24. Feng J, LaChance A, Sinclair DA, Asgari MM. Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1. BMJ Case Rep. 2019 Mar 08; 12(3).
    View in: PubMed
    Score: 0.018
  25. Roberts MR, Ashrafzadeh S, Asgari MM. Research Techniques Made Simple: Interpreting Measures?of Association in Clinical Research. J Invest Dermatol. 2019 03; 139(3):502-511.e1.
    View in: PubMed
    Score: 0.018
  26. Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A?cohort study. J Am Acad Dermatol. 2019 Apr; 80(4):998-1005.
    View in: PubMed
    Score: 0.018
  27. Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA, Gold DR, Thyssen JP, Litonjua AA, Oken E, Asgari MM. Racial/Ethnic Differences in Incidence and Persistence of Childhood Atopic Dermatitis. J Invest Dermatol. 2019 04; 139(4):827-834.
    View in: PubMed
    Score: 0.018
  28. Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM. Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma. Br J Dermatol. 2018 11; 179(5):1088-1094.
    View in: PubMed
    Score: 0.017
  29. Kim Y, Kraft P, Asgari MM. Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer. Br J Dermatol. 2018 06; 178(6):1241-1242.
    View in: PubMed
    Score: 0.017
  30. Wang W, Ollila HM, Whittemore AS, Demehri S, Ioannidis NM, Jorgenson E, Mignot E, Asgari MM. Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma. Cancer Immunol Immunother. 2018 Jul; 67(7):1123-1133.
    View in: PubMed
    Score: 0.017
  31. Jorgenson E, Choquet H, Yin J, Asgari MM. Common Mitochondrial Haplogroups and Cutaneous Squamous Cell Carcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):838-841.
    View in: PubMed
    Score: 0.017
  32. Sordillo JE, Kraft P, Wu AC, Asgari MM. Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2018 07; 138(7):1507-1510.
    View in: PubMed
    Score: 0.017
  33. Levandoski KA, Quesenberry CP, Tsai AL, Asgari MM. Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis. JAMA Dermatol. 2018 02 01; 154(2):218-219.
    View in: PubMed
    Score: 0.017
  34. Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis. J Am Acad Dermatol. 2018 04; 78(4):710-716.
    View in: PubMed
    Score: 0.017
  35. Dobry AS, Quesenberry CP, Asgari MM. Reply to: Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis". J Am Acad Dermatol. 2018 05; 78(5):e115.
    View in: PubMed
    Score: 0.016
  36. Wang W, Jorgenson E, Whittemore AS, Asgari MM. Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness. J Invest Dermatol. 2018 03; 138(3):557-561.
    View in: PubMed
    Score: 0.016
  37. Nguyen MO, Nguyen HT, Asgari MM. Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. Br J Dermatol. 2017 10; 177(4):901-902.
    View in: PubMed
    Score: 0.016
  38. Dobry AS, Quesenberry CP, Ray GT, Geier JL, Asgari MM. Serious infections among a large cohort of subjects with systemically treated psoriasis. J Am Acad Dermatol. 2017 Nov; 77(5):838-844.
    View in: PubMed
    Score: 0.016
  39. Asgari MM, Ray GT, Quesenberry CP, Katz KA, Silverberg MJ. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. JAMA Dermatol. 2017 09 01; 153(9):892-896.
    View in: PubMed
    Score: 0.016
  40. Wehner MR, Levandoski KA, Kulldorff M, Asgari MM. Research Techniques Made Simple: An Introduction to?Use and Analysis of Big Data in Dermatology. J Invest Dermatol. 2017 08; 137(8):e153-e158.
    View in: PubMed
    Score: 0.016
  41. Asgari MM, Shen L, Sokil MM, Yeh I, Jorgenson E. Prognostic factors and survival in acral lentiginous melanoma. Br J Dermatol. 2017 Aug; 177(2):428-435.
    View in: PubMed
    Score: 0.016
  42. Asgari MM, Chien AJ, Tsai AL, Fireman B, Quesenberry CP. Association between Lithium Use and?Melanoma Risk and Mortality: A?Population-Based Study. J Invest Dermatol. 2017 10; 137(10):2087-2091.
    View in: PubMed
    Score: 0.016
  43. Storer M, Zhu Z, Sokil M, Ford M, Neugebauer R, Asgari MM. Community-Based Practice Variations in Topical Treatment of Actinic Keratoses. JAMA Dermatol. 2017 05 01; 153(5):468-470.
    View in: PubMed
    Score: 0.016
  44. Yesantharao P, Wang W, Ioannidis NM, Demehri S, Whittemore AS, Asgari MM. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. Hum Immunol. 2017 Apr; 78(4):327-335.
    View in: PubMed
    Score: 0.016
  45. Asgari MM, Ray GT, Geier JL, Quesenberry CP. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017 Apr; 76(4):632-638.
    View in: PubMed
    Score: 0.016
  46. Ray GT, Kulldorff M, Asgari MM. Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population. JAMA Dermatol. 2016 11 01; 152(11):1218-1224.
    View in: PubMed
    Score: 0.015
  47. Asgari MM. Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes. J Invest Dermatol. 2016 11; 136(11):2128-2130.
    View in: PubMed
    Score: 0.015
  48. Whittemore AS, Wang W, Jorgenson E, Asgari MM. A GWAS of Cutaneous Squamous Cell Carcinoma-Letter. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1534.
    View in: PubMed
    Score: 0.015
  49. Asgari MM, Toland AE, Arron ST. IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in?Organ Transplant Recipients: A Pigment-Independent Phenomenon. J Invest Dermatol. 2017 01; 137(1):251-253.
    View in: PubMed
    Score: 0.015
  50. Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS. Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2016 05; 136(5):930-937.
    View in: PubMed
    Score: 0.014
  51. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. JAMA Dermatol. 2015 Sep; 151(9):976-81.
    View in: PubMed
    Score: 0.014
  52. Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol. 2015 Oct; 73(4):630-6.
    View in: PubMed
    Score: 0.014
  53. Asgari MM, Arron ST, Warton EM, Quesenberry CP, Weisshaar D. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant?recipients (SOTRs). J Am Acad Dermatol. 2015 Sep; 73(3):444-50.
    View in: PubMed
    Score: 0.014
  54. Asgari MM, Warton EM, Whittemore AS. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma. Dermatol Surg. 2015 Apr; 41(4):481-6.
    View in: PubMed
    Score: 0.014
  55. Asgari MM, Eide MJ, Warton M, Fletcher SW. Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries. Melanoma Res. 2014 Aug; 24(4):381-7.
    View in: PubMed
    Score: 0.013
  56. Asgari MM, Sokil MM, Warton EM, Iyer J, Paulson KG, Nghiem P. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol. 2014 Jul; 150(7):716-23.
    View in: PubMed
    Score: 0.013
  57. Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma. J Am Acad Dermatol. 2014 Sep; 71(3):521-8.
    View in: PubMed
    Score: 0.013
  58. Asgari M, Chen S. Papillary eccrine adenoma should not be mistaken for aggressive digital papillary adenocarcinoma. Clin Exp Dermatol. 2014 Mar; 39(2):223-4.
    View in: PubMed
    Score: 0.012
  59. Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, Herrinton LJ. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):842-9.
    View in: PubMed
    Score: 0.012
  60. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.012
  61. Asgari MM, Eide MJ, Warton EM, Fletcher SW. Validation of a large basal cell carcinoma registry. J Registry Manag. 2013; 40(2):65-9.
    View in: PubMed
    Score: 0.012
  62. Gordon NP, Caan BJ, Asgari MM. Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008. Nutr J. 2012 Dec 11; 11:104.
    View in: PubMed
    Score: 0.012
  63. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-12, quiz 815-6.
    View in: PubMed
    Score: 0.012
  64. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-11; quiz 827-8.
    View in: PubMed
    Score: 0.012
  65. Asgari MM, Brasky TM, White E. Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort. J Invest Dermatol. 2012 Jun; 132(6):1573-82.
    View in: PubMed
    Score: 0.011
  66. Olson JM, Alam M, Asgari MM. Needs assessment for general dermatologic surgery. Dermatol Clin. 2012 Jan; 30(1):153-66, x.
    View in: PubMed
    Score: 0.011
  67. Asgari MM, Olson JM, Alam M. Needs assessment for Mohs micrographic surgery. Dermatol Clin. 2012 Jan; 30(1):167-75, x.
    View in: PubMed
    Score: 0.011
  68. Asgari MM, Warton EM, Neugebauer R, Chren MM. Predictors of patient satisfaction with Mohs surgery: analysis of preoperative, intraoperative, and postoperative factors in a prospective cohort. Arch Dermatol. 2011 Dec; 147(12):1387-94.
    View in: PubMed
    Score: 0.011
  69. Alam M, Olson JM, Asgari MM. Needs assessment for cosmetic dermatologic surgery. Dermatol Clin. 2012 Jan; 30(1):177-87, x.
    View in: PubMed
    Score: 0.011
  70. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011 Dec; 65(6):1145-51.
    View in: PubMed
    Score: 0.010
  71. Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren MM. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; 63(2):314-8.
    View in: PubMed
    Score: 0.010
  72. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol. 2010 Apr; 146(4):388-95.
    View in: PubMed
    Score: 0.010
  73. Asgari MM, Efird JT, Warton EM, Friedman GD. Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study. Int J Environ Res Public Health. 2010 02; 7(2):427-42.
    View in: PubMed
    Score: 0.010
  74. Asgari MM, Tang J, Warton ME, Chren MM, Quesenberry CP, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol. 2010 May; 130(5):1438-43.
    View in: PubMed
    Score: 0.009
  75. Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol. 2009 Aug; 145(8):879-82.
    View in: PubMed
    Score: 0.009
  76. Asgari MM, Tang J, Epstein EH, Chren MM, Warton EM, Quesenberry CP, Go AS, Friedman GD. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.009
  77. Asgari MM, Bertenthal D, Sen S, Sahay A, Chren MM. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg. 2009 Jul; 35(7):1041-9.
    View in: PubMed
    Score: 0.009
  78. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol. 2009 Jul; 129(7):1675-80.
    View in: PubMed
    Score: 0.009
  79. Asgari MM, Maruti SS, White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst. 2008 Jul 02; 100(13):967-71.
    View in: PubMed
    Score: 0.009
  80. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008 Jun; 128(6):1409-17.
    View in: PubMed
    Score: 0.008
  81. Asgari MM, Cockerell CJ, Weitzul S. The head-tilt maneuver: a clinical aid in recognizing head and neck angiosarcomas. Arch Dermatol. 2007 Jan; 143(1):75-7.
    View in: PubMed
    Score: 0.008
  82. Asgari M, Leiferman KM, Piepkorn M, Kuechle MK. Neonatal eosinophilic pustulosis. Int J Dermatol. 2006 Feb; 45(2):131-4.
    View in: PubMed
    Score: 0.007
  83. Asgari M, Odland P. Nasalis island pedicle flap in nasal ala reconstruction. Dermatol Surg. 2005 Apr; 31(4):448-52.
    View in: PubMed
    Score: 0.007
  84. Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg. 2004 Oct; 30(10):1335-42.
    View in: PubMed
    Score: 0.007
  85. George CD, Lee T, Hollestein LM, Asgari MM, Nijsten T. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. Br J Dermatol. 2024 03 15; 190(4):465-476.
    View in: PubMed
    Score: 0.006
  86. Asgari M, Rubin BP, Hornung RL. Neonate with a fibrosarcoma and consumptive coagulopathy. J Am Acad Dermatol. 2004 Feb; 50(2 Suppl):S23-5.
    View in: PubMed
    Score: 0.006
  87. Khoshbakht R, Semsari Bonab M, Hajizadegan H, Tavakolizadeh Nooghabi E, Ghorbani A, Asgari M, Neshani A, Ghavidel M, Sadeghian H. Comparing self-medication and medical supervised treatment before hospitalization among patients with Covid-19: A retrospective case-control study. J Infect Public Health. 2023 Dec; 16 Suppl 1:119-124.
    View in: PubMed
    Score: 0.006
  88. Wei AZ, Chen LN, Orloff M, Ariyan CE, Asgari M, Barker CA, Buchbinder E, Chandra S, Couts K, Frumovitz MM, Futreal A, Gershenwald JE, Hanna EY, Izar B, LeBlanc AK, Leitao MM, Lipson EJ, Liu D, McCarter M, McQuade JL, Najjar Y, Rapisuwon S, Selig S, Shoushtari AN, Yeh I, Schwartz GK, Guo J, Patel SP, Carvajal RD. Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment Cell Melanoma Res. 2023 11; 36(6):542-556.
    View in: PubMed
    Score: 0.006
  89. Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, N?meth IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 02; 90(2):288-298.
    View in: PubMed
    Score: 0.006
  90. Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 07; 112(1):E27-E29.
    View in: PubMed
    Score: 0.006
  91. Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 03 10; 13(3):e071172.
    View in: PubMed
    Score: 0.006
  92. Nguyen N, Wan G, Ugwu-Dike P, Alexander NA, Raval N, Zhang S, Jairath R, Phillipps J, Leung B, Roster K, Seo J, Lu C, Tang K, Choi MS, DeSimone MS, Theodosakis N, Amadife M, Cox N, Le TK, Liu F, Chen W, Bai X, Boland G, Liu D, Hurlbert MS, LeBoeuf N, Reynolds KL, Yu KH, Tsao H, Asgari M, Gusev A, Kwatra SG, Semenov YR. Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy. J Am Acad Dermatol. 2023 06; 88(6):1308-1316.
    View in: PubMed
    Score: 0.006
  93. Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug; 315(6):1583-1592.
    View in: PubMed
    Score: 0.006
  94. Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: A retrospective cohort study. PLoS One. 2022; 17(11):e0277469.
    View in: PubMed
    Score: 0.006
  95. Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens MR, Estiri H, Lilly E, Asgari M, Semenov YR. Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated". J Am Acad Dermatol. 2022 07; 87(1):e47-e48.
    View in: PubMed
    Score: 0.006
  96. Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy. JAMA Dermatol. 2022 Feb 01; 158(2):189-193.
    View in: PubMed
    Score: 0.005
  97. Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR. Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol. 2022 10; 87(4):866-867.
    View in: PubMed
    Score: 0.005
  98. Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bouwes Bavinck JN, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Mu?oz B, Ferr?ndiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Olasz Harken EB, Hofbauer GFL, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascar? JM, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, R?cz E, Ruiz-Salas V, Samie FH, Se?kin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. JAMA Dermatol. 2021 Oct 01; 157(10):1219-1226.
    View in: PubMed
    Score: 0.005
  99. Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens RM, Estir H, Lilly E, Asgari M, Semenov YR. Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts. J Am Acad Dermatol. 2022 01; 86(1):252-255.
    View in: PubMed
    Score: 0.005
  100. Ashrafzadeh S, Asgari MM, Geller AC. The Need for Critical Examination of Disparities in Immunotherapy and Targeted Therapy Use Among Patients With Cancer. JAMA Oncol. 2021 08 01; 7(8):1115-1116.
    View in: PubMed
    Score: 0.005
  101. Kem?ny LV, Robinson KC, Hermann AL, Walker DM, Regan S, Yew YW, Lai YC, Theodosakis N, Rivera PD, Ding W, Yang L, Beyer T, Loh YE, Lo JA, van der Sande AAJ, Sarnie W, Kotler D, Hsiao JJ, Su MY, Kato S, Kotler J, Bilbo SD, Chopra V, Salomon MP, Shen S, Hoon DSB, Asgari MM, Wakeman SE, Nestler EJ, Fisher DE. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Sci Adv. 2021 06; 7(24).
    View in: PubMed
    Score: 0.005
  102. Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE. Guidelines of care for the management of actinic keratosis: Executive summary. J Am Acad Dermatol. 2021 10; 85(4):945-955.
    View in: PubMed
    Score: 0.005
  103. Berg D, Asgari M. Evidence-based medicine for dermatologic surgeons: concepts in critical appraisal of information. Dermatol Surg. 2001 Jun; 27(6):511-4.
    View in: PubMed
    Score: 0.005
  104. Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021 10; 85(4):e209-e233.
    View in: PubMed
    Score: 0.005
  105. Choquet H, Ashrafzadeh S, Kim Y, Asgari MM, Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020 05 21; 5(10).
    View in: PubMed
    Score: 0.005
  106. Sarin KY, Lin Y, Daneshjou R, Ziyatdinov A, Thorleifsson G, Rubin A, Pardo LM, Wu W, Khavari PA, Uitterlinden A, Nijsten T, Toland AE, Olafsson JH, Sigurgeirsson B, Thorisdottir K, Jorgensen E, Whittemore AS, Kraft P, Stacey SN, Stefansson K, Asgari MM, Han J. Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun. 2020 02 10; 11(1):820.
    View in: PubMed
    Score: 0.005
  107. Strickley JD, Messerschmidt JL, Awad ME, Li T, Hasegawa T, Ha DT, Nabeta HW, Bevins PA, Ngo KH, Asgari MM, Nazarian RM, Neel VA, Jenson AB, Joh J, Demehri S. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019 11; 575(7783):519-522.
    View in: PubMed
    Score: 0.005
  108. Ameri AH, Mooradian MJ, Emerick KS, Park JC, Wirth LJ, Asgari MM, Tsao H, Lawrence D, Sullivan RJ, Demehri S. Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum. Br J Dermatol. 2019 11; 181(5):1095-1097.
    View in: PubMed
    Score: 0.005
  109. Roberts MR, Asgari MM, Toland AE. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Br J Dermatol. 2019 12; 181(6):1146-1155.
    View in: PubMed
    Score: 0.005
  110. Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res. 2019 04 15; 25(8):2379-2391.
    View in: PubMed
    Score: 0.004
  111. Ioannidis NM, Wang W, Furlotte NA, Hinds DA, Bustamante CD, Jorgenson E, Asgari MM, Whittemore AS. Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma. Nat Commun. 2018 10 15; 9(1):4264.
    View in: PubMed
    Score: 0.004
  112. Feng J, Kim Y, Kornides ML, McRee AL, Mays D, Asgari MM, Gilkey MB. Correlates of positive parental attitudes towards adolescent indoor tanning in the U.S.A. Br J Dermatol. 2018 12; 179(6):1412-1413.
    View in: PubMed
    Score: 0.004
  113. Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 02; 80(2):577-578.
    View in: PubMed
    Score: 0.004
  114. Wang W, Jorgenson E, Ioannidis NM, Asgari MM, Whittemore AS. A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous?Cell?Skin Cancer. J Invest Dermatol. 2018 12; 138(12):2589-2594.
    View in: PubMed
    Score: 0.004
  115. Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM. How data can deliver for dermatology. J Am Acad Dermatol. 2018 08; 79(2):400-402.
    View in: PubMed
    Score: 0.004
  116. Tang H, Fu S, Zhai S, Song Y, Asgari MM, Han J. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2018 03; 27(3):279-288.
    View in: PubMed
    Score: 0.004
  117. Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE. Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma. Br J Dermatol. 2017 11; 177(5):1150-1151.
    View in: PubMed
    Score: 0.004
  118. Blomberg M, He SY, Harwood C, Arron ST, Demehri S, Green A, Asgari MM. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017 Nov; 177(5):1225-1233.
    View in: PubMed
    Score: 0.004
  119. Secrest AM, Asgari MM, Kourosh AS, Barbieri JS, Albrecht J. Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff. J Am Acad Dermatol. 2017 10; 77(4):784-786.
    View in: PubMed
    Score: 0.004
  120. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
    View in: PubMed
    Score: 0.004
  121. Jiang AJ, Eide MJ, Alexander GL, Altschuler A, Asgari MM, Geller AC, Fletcher SW, Halpern AC, Weinstock MA. Providers' Experiences with a Melanoma Web-Based Course: a Discussion on Barriers and Intentions. J Cancer Educ. 2017 Jun; 32(2):272-279.
    View in: PubMed
    Score: 0.004
  122. Gilkey MB, Mays D, Asgari MM, Kornides ML, McRee AL. Parental Support for Age-based Indoor Tanning Restrictions. Am J Prev Med. 2017 Oct; 53(4):473-480.
    View in: PubMed
    Score: 0.004
  123. Blomberg M, Rifas-Shiman SL, Camargo CA, Gold DR, Asgari MM, Thyssen JP, Litonjua AA, Gillman MW, Oken E. Low Maternal Prenatal 25-Hydroxyvitamin D Blood Levels Are Associated with Childhood Atopic Dermatitis. J Invest Dermatol. 2017 06; 137(6):1380-1384.
    View in: PubMed
    Score: 0.004
  124. Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H, Asgari MM, Huang ML, Schwartz SM, Nghiem P. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. J Invest Dermatol. 2017 04; 137(4):819-827.
    View in: PubMed
    Score: 0.004
  125. Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, Wu JJ, Herrinton LJ. Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. Perm J. 2016; 20(4):15-151.
    View in: PubMed
    Score: 0.004
  126. Albrecht J, Lebwohl M, Asgari MM, Bennett DD, Cook A, Evans CC, Green LJ, Hodge JA, Kourosh AS, Maloney ME, Howard LM, Olsen EA, Rosenberg SP, Rubin A, Stough DB, Taylor SC, Brod BA. The state and consequences of dermatology drug prices in the United States. J Am Acad Dermatol. 2016 Sep; 75(3):603-605.
    View in: PubMed
    Score: 0.004
  127. Iyer JG, Parvathaneni K, Bhatia S, Tarabadkar ES, Blom A, Doumani R, McKenzie J, Asgari MM, Nghiem P. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations. J Am Acad Dermatol. 2016 Sep; 75(3):541-547.
    View in: PubMed
    Score: 0.004
  128. Herrinton LJ, Harrold L, Salman C, Liu L, Goldfien R, Asgari M, Gelfand JM, Wu JJ, Curtis JR. Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. Perm J. 2016; 20(1):4-12.
    View in: PubMed
    Score: 0.004
  129. Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):262-70.
    View in: PubMed
    Score: 0.004
  130. Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases. Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):684-92.
    View in: PubMed
    Score: 0.003
  131. Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP, Schaefer C, Van Den Eeden SK, Risch N, Witte JS. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.003
  132. Talaiezadeh AH, Asgari M, Zargar MA. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas. Asian Pac J Cancer Prev. 2015; 16(13):5253-6.
    View in: PubMed
    Score: 0.003
  133. Huynh JC, Asgari MM, Moore MM. Sebotropic eruption associated with use of oral kava kava supplement. Clin Exp Dermatol. 2014 Oct; 39(7):816-8.
    View in: PubMed
    Score: 0.003
  134. Paulson KG, Iyer JG, Simonson WT, Blom A, Thibodeau RM, Schmidt M, Pietromonaco S, Sokil M, Warton EM, Asgari MM, Nghiem P. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol. 2014 Oct; 142(4):452-8.
    View in: PubMed
    Score: 0.003
  135. Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ. Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol. 2014 Oct; 28(10):1380-7.
    View in: PubMed
    Score: 0.003
  136. Eide MJ, Asgari MM, Fletcher SW, Geller AC, Halpern AC, Shaikh WR, Li L, Alexander GL, Altschuler A, Dusza SW, Marghoob AA, Quigley EA, Weinstock MA. Effects on skills and practice from a web-based skin cancer course for primary care providers. J Am Board Fam Med. 2013 Nov-Dec; 26(6):648-57.
    View in: PubMed
    Score: 0.003
  137. Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol. 2013 Jul; 40(7):1218-25.
    View in: PubMed
    Score: 0.003
  138. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer. 2013 Apr 15; 119(8):1562-9.
    View in: PubMed
    Score: 0.003
  139. Shaikh WR, Geller A, Alexander G, Asgari MM, Chanange GJ, Dusza S, Eide MJ, Fletcher SW, Goulart JM, Halpern AC, Landow S, Marghoob AA, Quigley EA, Weinstock MA. Developing an interactive web-based learning program on skin cancer: the learning experiences of clinical educators. J Cancer Educ. 2012 Dec; 27(4):709-16.
    View in: PubMed
    Score: 0.003
  140. Paulson KG, Iyer JG, Blom A, Warton EM, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM, Nghiem P. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol. 2013 Mar; 133(3):642-646.
    View in: PubMed
    Score: 0.003
  141. Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012 Sep 10; 172(16):1246-51.
    View in: PubMed
    Score: 0.003
  142. Loeb KR, Asgari MM, Hawes SE, Feng Q, Stern JE, Jiang M, Argenyi ZB, de Villiers EM, Kiviat NB. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One. 2012; 7(4):e34422.
    View in: PubMed
    Score: 0.003
  143. Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2012 Mar; 23(3):431-44.
    View in: PubMed
    Score: 0.003
  144. Wilson LS, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012 Apr; 38(4):570-84.
    View in: PubMed
    Score: 0.003
  145. Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, Asgari M, Shoveller J, Press N, Burke W. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012 Jan; 33(1):85-92.
    View in: PubMed
    Score: 0.003
  146. Goulart JM, Quigley EA, Dusza S, Jewell ST, Alexander G, Asgari MM, Eide MJ, Fletcher SW, Geller AC, Marghoob AA, Weinstock MA, Halpern AC. Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med. 2011 Sep; 26(9):1027-35.
    View in: PubMed
    Score: 0.003
  147. Harris JN, Hay J, Kuniyuki A, Asgari MM, Press N, Bowen DJ. Using a family systems approach to investigate cancer risk communication within melanoma families. Psychooncology. 2010 Oct; 19(10):1102-11.
    View in: PubMed
    Score: 0.003
  148. Tang JY, Wu A, Linos E, Parimi N, Lee W, Aszterbaum M, Asgari MM, Bickers DR, Epstein EH. High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. Arch Dermatol. 2010 Oct; 146(10):1105-10.
    View in: PubMed
    Score: 0.003
  149. Eide MJ, Krajenta R, Johnson D, Long JJ, Jacobsen G, Asgari MM, Lim HW, Johnson CC. Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data. Am J Epidemiol. 2010 Jan 01; 171(1):123-8.
    View in: PubMed
    Score: 0.002
  150. Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarr? G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol. 2009 Oct; 61(4):677.e1-14.
    View in: PubMed
    Score: 0.002
  151. Akhyani M, Chams-Davatchi C, Naraghi Z, Daneshpazhooh M, Toosi S, Asgari M, Malekhami F. Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases. Br J Dermatol. 2008 Mar; 158(3):478-82.
    View in: PubMed
    Score: 0.002
  152. Hay JL, Meischke HW, Bowen DJ, Mayer J, Shoveller J, Press N, Asgari M, Berwick M, Burke W. Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges. Ann Behav Med. 2007 Nov-Dec; 34(3):275-86.
    View in: PubMed
    Score: 0.002
  153. Chien AJ, Asgari M, Argenyi ZB. Eccrine angiomatous hamartoma with elements of an arterio-venous malformation: a newly recognized variant. J Cutan Pathol. 2006 Jun; 33(6):433-6.
    View in: PubMed
    Score: 0.002
  154. Wang XM, McNiff JM, Klump V, Asgari M, Gasparro FP. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA. Photochem Photobiol. 1997 Aug; 66(2):294-9.
    View in: PubMed
    Score: 0.001
  155. Asgari M, Owrang A. Results of skin test surveys for systemic mycoses in Iran. Mycopathol Mycol Appl. 1970; 41(1):91-106.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)